Saitama Medical University · Faculty of Medicine / Graduate School of Medicine · 講師

Research keywordsEGFR-mutated non-small cell lung cancer・immune checkpoint inhibitors・platinum doublet chemotherapy・BRAF V600E resistance・osimertinib retreatment・dabrafenib plus trametinib・small-cell transformation・ocular cicatricial pemphigoid

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Erlotinib-Induced Ocular Cicatricial Pemphigoid in EGFR-Mutated Non–Small Cell Lung Cancer: A Case Report2026 · Clinical Lung Cancer
• Efficacy of osimertinib resumption with dabrafenib and trametinib for elderly patients with EGFR-mutated lung adenocarcinoma harboring acquired BRAF V600E resistant mutation resistant to Osimertinib2025 · Japanese Journal of Clinical Oncology
• Efficacy of Immune Checkpoint Inhibitors in Combination With Platinum-Based Doublet Chemotherapy for Extensive Stage Small-Cell Lung Cancer Patients With Eastern Cooperative Oncology Group-Performance Status 2–3: A Single-Institution Retrospective Study2025 · Cancer Medicine
• Immunotherapy with radiotherapy for brain metastases in non-small cell lung cancer patients: NEJ0602024 · JTO Clinical and Research Reports

• 2024～2026 胸膜中皮腫におけるDishevelled-3抑制による抗腫瘍効果の増強因子の探索 基盤研究(C)2024 · 研究課題・受託研究・科研費
• 胸膜中皮腫におけるDishevelled-3抑制による抗腫瘍効果の増強因子の探索2024

• Official profile
• ORCID